Prior to administering oral doses of calcitriol and calcium carbonate to a client with hypoparathyroidism, the nurse notes that the total level of calcium is 14 mg/dL (3.5 mmol/L). Which action should the nurse implement?
A.
Administer both prescribed medications as scheduled.
B.
Hold the calcitriol but administer the calcium carbonate as scheduled.
C.
Hold the calcium carbonate but administer the calcitriol as scheduled.
D.
Hold both medications until contacting the healthcare provider.
The correct answer and Explanation is :
Correct Answer: D. Hold both medications until contacting the healthcare provider.
Explanation:
The patient’s total calcium level is 14 mg/dL, which is elevated. Normal total calcium levels typically range from 8.5 to 10.2 mg/dL. In this case, the level is significantly higher, indicating hypercalcemia. Hypercalcemia can be dangerous and requires careful management.
Calcitriol is a form of vitamin D that increases calcium absorption from the gut. When administered to someone with normal or elevated calcium levels, calcitriol could exacerbate hypercalcemia, potentially leading to severe complications like kidney stones, cardiac arrhythmias, or neurological symptoms.
Calcium carbonate is a supplement used to increase calcium levels, and in this scenario, it is likely being given to manage hypoparathyroidism or to correct calcium deficiencies. However, administering calcium carbonate in the context of elevated calcium levels would worsen the hypercalcemia.
Given the elevated calcium level of 14 mg/dL, it is essential to avoid both increasing calcium intake and enhancing its absorption. Therefore, holding both calcitriol and calcium carbonate is the prudent action. This approach prevents further elevation of calcium levels and allows for a thorough evaluation by the healthcare provider.
The healthcare provider would need to assess the patient further to determine the cause of the hypercalcemia and to decide on the appropriate course of action. Treatment may involve discontinuing calcium and vitamin D supplements, addressing any underlying conditions, or providing alternative therapies to correct calcium imbalances safely.
In summary, holding both medications until the healthcare provider can review the patient’s condition and make a tailored treatment decision is the safest course of action to prevent complications associated with hypercalcemia.